News tagged with asthma drugs

FDA approves once-a-day inhaler from Glaxo

The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.

Medications May 10, 2013 | not rated yet | 0

Nearly 5 million asthmatics could benefit from antifungal therapy

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.

Inflammatory disorders May 08, 2013 | not rated yet | 0

Oral drops can give kids needle-free relief from asthma, allergies

Allergy shots are commonly used to treat children with severe environmental allergies and asthma, but under-the-tongue drops may offer yet another beneficial—and stick-free—option for pediatric allergy sufferers, according ...

Immunology May 06, 2013 | not rated yet | 0

US panel backs inhaler drug for lung disease

A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.

Medications Apr 17, 2013 | not rated yet | 0

Studies for approval of new drugs have insufficient patients to evaluate safety

For medicines intended for chronic use, the number of patients studied before regulatory approval is insufficient to properly evaluate safety and long-term efficacy, requiring the need for new legislation, according to a ...

Medications Mar 19, 2013 | not rated yet | 0

Scientists discover molecule that does double duty in stopping asthma attacks

Scientists from Brigham and Women's Hospital are on the brink of the next treatment advancement that may spell relief for the nearly nineteen million adults and seven million children in the United States ...

Inflammatory disorders Feb 27, 2013 | 5 / 5 (3) | 0 |

1990s trial gave early danger signs for asthma drugs

The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.

Medications Nov 25, 2012 | not rated yet | 0

Healthcare professionals as bad as patients at good respiratory inhaler technique

Healthcare professionals are as bad as patients when it comes to knowing how to use inhalers prescribed for asthma and other respiratory conditions correctly, says an editorial in Drug and Therapeutics Bulletin (DTB).

Diseases, Conditions, Syndromes Oct 03, 2012 | not rated yet | 0

Children taking steroids for asthma are slightly shorter than peers

Children who use inhaled steroid drugs for asthma end up slightly shorter at their full adult height than children who don't use the drugs, new results from a comprehensive asthma study show.

Immunology Sep 03, 2012 | 5 / 5 (1) | 1 |

Stopping controversial asthma drugs could have downside: study

(HealthDay)—It's OK for some patients with asthma to stick with a combination of medications instead of abandoning one because of concerns about complications, a new analysis of existing research suggests.

Immunology Aug 27, 2012 | not rated yet | 0

First generic versions of singulair approved

(HealthDay) -- The first generic versions of Singulair (montelukast sodium) have been approved by the U.S. Food and Drug Administration.

Medications Aug 04, 2012 | not rated yet | 0

Team finds new type of severe asthma, can be treated with drugs that suppress the immune system

(Medical Xpress) -- Researchers at the University of Pittsburgh School of Medicine have identified a subset of severe asthma that improves with drug regimens that suppress the immune system. In the American Journal of Respiratory and Critical Care Medicine, they dubbed the condition “asthmatic gr ...

Immunology Jul 19, 2012 | not rated yet | 0

Pages: 1 2
Next »